Delivery Order SPE2DR25D3109-SPE2DR26FT2MU
Award Date 1/13/26
Potential Completion Date 1/14/26
Potential Value $1.7K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Quillivant XR 25 mg/5 mL suspension (180 mL), a pharmaceutical product used to treat attention deficit hyperactivity disorder. The contract is a firm fixed-price delivery order with a ceiling value of $3,893.03 and an ultimate completion date of November 26, 2025. This award was made on a competitive basis with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $4,827.25 on October 23, 2025, with an ultimate completion date of October 24, 2025. The order is for Quillivant XR 25 mg/5 ml suspension in a 120 ml quantity, a brand-name ADHD medication. This competitive, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- On January 14, 2026, the Defense Logistics Agency awarded a delivery order valued at $5,373.26 to AmerisourceBergen Drug Corp for the supply of Quillivant XR 25 mg/5 ml suspension (60 ml). The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating full and open competition. Performance will be conducted at the awardee's location in Conshohocken, Pennsylvania, with an ultimate completion date of January 15, 2026. AmerisourceBergen Drug Corp, a...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Quillivant XR oral suspension (60mL, 5mg/mL), a medication used to treat attention deficit hyperactivity disorder. This competitively awarded, firm fixed-price delivery order has a ceiling value of $8,284.62 and is scheduled for completion by October 28, 2025. The contract was placed with AmerisourceBergen's Corporate Office location in Conshohocken,...
- On January 7, 2026, the Defense Logistics Agency awarded a delivery order valued at $4,552.30 to AmerisourceBergen Drug Corp for the supply of Quillivant XR 25 mg/5 mL suspension (120 mL). The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. Performance will be executed from the awardee's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 8, 2026. AmerisourceBergen Drug Corp, a subsidiary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Quillivant XR 25 mg/5 mL suspension (180 mL), a medication commonly used to treat attention deficit hyperactivity disorder. The order, valued at $1,372.61, represents a firm fixed-price delivery order with an ultimate completion date of December 8, 2025. This award was not issued under any set-aside designation, indicating it was competitively awarded. AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $3,749.73 to AmerisourceBergen Drug Corp for the supply of Quillivant XR 25mg, an ADHD medication commonly used in military healthcare systems. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement with a completion date of January 12, 2026. The delivery order was issued on December 12, 2025, with performance to occur at the contractor's facility in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,017.92 to AmerisourceBergen Drug Corp for the supply of Quillivant XR 25 mg/5 mL suspension (180 mL), a medication commonly used to treat attention deficit hyperactivity disorder. The award was issued on January 7, 2026, with an ultimate completion date of January 8, 2026, and utilizes firm fixed-price pricing with no set-aside designation. Performance will take place at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $2,534.24 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Quillivant XR 25 mg/5 mL suspension (60 mL), a methylphenidate-based medication used to treat attention deficit hyperactivity disorder. This firm fixed-price delivery order, with an ultimate completion date of December 4, 2025, was competitively awarded without a set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Quillivant XR 25 mg/5 mL suspension in 60 mL quantities, with a ceiling value of $4,706.40 and an ultimate completion date of December 9, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a continuation of the federal...